| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 8888888 |
Internal/system code - not a standard HCPCS code |
30,801 |
15,287 |
$12.71M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,304 |
9,342 |
$525K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,738 |
17,210 |
$523K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,368 |
9,131 |
$350K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,972 |
11,358 |
$333K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,931 |
2,411 |
$295K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,913 |
1,783 |
$248K |
| 80050 |
General health panel |
1,800 |
1,693 |
$149K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,615 |
4,988 |
$104K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,484 |
2,276 |
$100K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,159 |
1,588 |
$94K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,503 |
2,018 |
$87K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,913 |
1,741 |
$76K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,816 |
1,650 |
$75K |
| 85027 |
|
1,880 |
1,562 |
$69K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,079 |
5,014 |
$66K |
| 71045 |
Radiologic examination, chest; single view |
3,237 |
2,953 |
$59K |
| 81001 |
|
8,263 |
7,143 |
$58K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,488 |
1,666 |
$54K |
| 71046 |
Radiologic examination, chest; 2 views |
1,577 |
1,456 |
$49K |
| J2704 |
Injection, propofol, 10 mg |
3,563 |
3,206 |
$49K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,331 |
6,800 |
$47K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,950 |
938 |
$47K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,578 |
2,610 |
$47K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,326 |
3,001 |
$43K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,363 |
2,401 |
$43K |
| 74018 |
|
911 |
795 |
$40K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,812 |
1,550 |
$40K |
| 80053 |
Comprehensive metabolic panel |
16,878 |
14,130 |
$38K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,338 |
3,425 |
$37K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,851 |
7,088 |
$36K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,377 |
677 |
$34K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
836 |
781 |
$33K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,096 |
926 |
$30K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,270 |
2,036 |
$30K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
221 |
210 |
$29K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
291 |
155 |
$28K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,498 |
4,622 |
$27K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,528 |
2,288 |
$27K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
901 |
837 |
$27K |
| J2060 |
Injection, lorazepam, 2 mg |
1,931 |
1,533 |
$24K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
169 |
161 |
$22K |
| 81025 |
|
1,007 |
931 |
$22K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,445 |
3,958 |
$21K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
300 |
290 |
$20K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
784 |
742 |
$18K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
648 |
600 |
$17K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,548 |
1,222 |
$16K |
| 84702 |
|
1,856 |
1,575 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,316 |
2,905 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,849 |
1,749 |
$12K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,266 |
1,002 |
$11K |
| 87631 |
|
157 |
147 |
$11K |
| 96376 |
|
3,081 |
2,481 |
$11K |
| 82247 |
|
1,794 |
943 |
$11K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,949 |
1,473 |
$10K |
| 84703 |
|
2,369 |
2,150 |
$10K |
| 86901 |
|
683 |
617 |
$8K |
| 81003 |
|
314 |
289 |
$8K |
| 84484 |
|
2,307 |
1,988 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,183 |
1,008 |
$8K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,234 |
2,075 |
$8K |
| 73630 |
|
162 |
150 |
$7K |
| 83690 |
|
5,590 |
4,822 |
$7K |
| 97161 |
|
62 |
59 |
$7K |
| 87081 |
|
271 |
257 |
$7K |
| 87186 |
|
838 |
759 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
29 |
29 |
$6K |
| 85379 |
|
1,336 |
1,235 |
$5K |
| 76830 |
Ultrasound, transvaginal |
308 |
296 |
$5K |
| 80061 |
Lipid panel |
1,410 |
1,350 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
323 |
309 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
204 |
183 |
$4K |
| 73610 |
|
62 |
52 |
$3K |
| 85610 |
|
1,049 |
849 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,280 |
2,116 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,018 |
985 |
$3K |
| 85651 |
|
1,753 |
1,523 |
$3K |
| 93971 |
|
119 |
105 |
$3K |
| 84439 |
|
1,237 |
1,172 |
$3K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
13 |
12 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
26 |
25 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
27 |
24 |
$2K |
| J1630 |
Injection, haloperidol, up to 5 mg |
372 |
314 |
$2K |
| 86140 |
|
2,886 |
2,490 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
829 |
802 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
50 |
48 |
$2K |
| 76642 |
|
128 |
108 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
90 |
79 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
879 |
778 |
$2K |
| 83735 |
|
1,262 |
927 |
$2K |
| 73110 |
|
26 |
24 |
$1K |
| 73130 |
|
20 |
16 |
$1K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
13 |
12 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
107 |
103 |
$1K |
| 80164 |
|
126 |
116 |
$1K |
| 76801 |
|
31 |
26 |
$1K |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
12 |
12 |
$982.06 |
| 87807 |
|
12 |
12 |
$974.26 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
393 |
343 |
$856.26 |
| 83605 |
|
1,379 |
1,201 |
$585.46 |
| 86850 |
|
200 |
179 |
$583.35 |
| 73562 |
|
12 |
12 |
$564.12 |
| 82570 |
|
117 |
99 |
$444.96 |
| 73030 |
|
19 |
15 |
$418.40 |
| 82550 |
|
30 |
25 |
$384.24 |
| 82565 |
|
95 |
91 |
$359.47 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
12 |
$344.28 |
| 82805 |
|
14 |
12 |
$339.27 |
| 84146 |
|
96 |
92 |
$289.91 |
| 84481 |
|
15 |
15 |
$288.69 |
| 72100 |
|
13 |
12 |
$245.20 |
| 83516 |
|
27 |
26 |
$229.15 |
| 85007 |
|
448 |
361 |
$218.57 |
| 85730 |
|
129 |
122 |
$169.18 |
| 84466 |
|
58 |
54 |
$159.45 |
| 87040 |
|
819 |
645 |
$149.63 |
| 82728 |
|
79 |
71 |
$146.25 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
482 |
455 |
$127.22 |
| 83880 |
|
302 |
277 |
$118.95 |
| 84156 |
|
51 |
41 |
$107.13 |
| 86900 |
|
85 |
74 |
$105.16 |
| 80178 |
|
13 |
12 |
$100.40 |
| 87088 |
|
638 |
580 |
$96.99 |
| 82607 |
|
121 |
118 |
$88.19 |
| 82248 |
|
16 |
13 |
$71.10 |
| 36415 |
Collection of venous blood by venipuncture |
36 |
30 |
$52.24 |
| J3490 |
Unclassified drugs |
44 |
41 |
$36.58 |
| 84132 |
|
38 |
37 |
$0.00 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
29 |
29 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
106 |
102 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
154 |
146 |
$0.00 |
| 83615 |
|
176 |
162 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
31 |
27 |
$0.00 |
| 88304 |
|
40 |
38 |
$0.00 |
| 90686 |
|
57 |
54 |
$0.00 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
27 |
25 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
26 |
25 |
$0.00 |
| 87070 |
|
18 |
17 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
12 |
$0.00 |
| 83540 |
|
61 |
58 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
144 |
128 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
13 |
12 |
$0.00 |
| 84100 |
|
18 |
13 |
$0.00 |
| 87075 |
|
13 |
13 |
$0.00 |